Product Details:
| Dose | 500mg |
| Product Type | Finished Product |
| Dosage Form | Injection |
| Brand | astrazeneca |
| API Form | Powder |
| Medicine Type | Allopathic |
| Packaging Type | Bottles |
Product Details:
| Dose/Strength | 500mg |
| Manufactured By | lilly |
| Packaging Type | vial |
| Usage/Application | cancer |
| Dosage Form | injection |
| Form of Medicine | vial |
| Brand | alimta |
| Usage | Personal |
Alimta is approved for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy.
Available As: 100 Mg Injection & 500 Mg Injection
Additional Information:
Product Details:
| Dose/Strength | 500mg |
| Composition | pemetrexed |
| Drug Name | pemetrexed |
| Packaging Size | vial |
| Brand | alimta |
| Dose | 500mg |
| Packaging Type | vial |
| Dosage Form | vial |
We are engaged in offering Alimta, which is used in combination with cisplatin for treatment of metastatic nonsquamous non-small cell lung cancer. Our range is prescribed for the patients, whose disease has not progressed after 4 cycles of platinum-based 1st-line chemotherapy or as a single agent after prior chemotherapy. We offer these products in customized packaging and at cost effective prices to our valued clients.
Other Information
Pay Mode Terms: L/C (Letter of Credit), D/A (Documents against Acceptance), D/P (Documents against Payment), T/T (Bank Transfer), Western Union, Other
Product Details:
| Manufactured By | lilly |
| Drug Name | pemetrexed |
| Packaging Type | vial |
| Dose/Strength | 500mg |
| Gender | Unisex |
| Dosage Form | vial |
| Form of Medicine | injection |
| Storage Condition | room temprature |
| Quantity Per Pack | 500mg |
| Brand | alimta |
| Usage | Commercial |
Alimta 500mg
Alimta Supplier
Alimta Lilly
Additional Information:
Product Details:
| Brand | Pemgem |
| Packaging Type | vial |
| Usage/Application | inj |
| Composition | Pemetrexed |
| Drug Name | Pemetrexed |
| Dose/Strength | 500mg |
| Dosage Form | vial |
| Form of Medicine | Injection |
Generic Content-Pemetrexed, Manufactured By: Dr.Reddy’s Lab,India
Pemgem is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. Pemgem is not indicated for patients who have a different type of NSCLC called squamous cell.